Author:
Yoshikawa Haruka,Hosokawa Maiko,Kashima Yuki,Oki Sayaka,Masui Kenichi
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference13 articles.
1. Correlation of the dose of midazolam for symptom control with administration periods: the possibility of tolerance.;Morita;J Pain Symptom Manage,2003
2. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!;Masui;J Anesth,2020
3. Psychotropic dose equivalence in Japan.;Inada;Psychiatry Clin Neurosci,2015
4. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial.;Doi;J Anesth,2020
5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.;Antonik;Anesth Analg,2012
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献